Literature DB >> 19667198

A role for the TGFbeta-Par6 polarity pathway in breast cancer progression.

Alicia M Viloria-Petit1, Laurent David, Jun Yong Jia, Tuba Erdemir, Anita L Bane, Dushanthi Pinnaduwage, Luba Roncari, Masahiro Narimatsu, Rohit Bose, Jason Moffat, John W Wong, Robert S Kerbel, Frances P O'Malley, Irene L Andrulis, Jeffrey L Wrana.   

Abstract

The role of polarity signaling in cancer metastasis is ill defined. Using two three-dimensional culture models of mammary epithelial cells and an orthotopic mouse model of breast cancer, we reveal that Par6 signaling, which is regulated directly by TGFbeta, plays a role in breast cancer metastasis. Interference with Par6 signaling blocked TGFbeta-dependent loss of polarity in acini-like structures formed by non-transformed mammary cells grown in three-dimensional structures and suppressed the protrusive morphology of mesenchymal-like invasive mammary tumor cells without rescuing E-cadherin expression. Moreover, blockade of Par6 signaling in an in vivo orthotopic model of metastatic breast cancer induced the formation of ZO-1-positive epithelium-like structures in the primary tumor and suppressed metastasis to the lungs. Analysis of the pathway in tissue microarrays of human breast tumors further revealed that Par6 activation correlated with markers of the basal carcinoma subtype in BRCA1-associated tumors. These studies thus reveal a key role for polarity signaling and the control of morphologic transformation in breast cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19667198      PMCID: PMC2729014          DOI: 10.1073/pnas.0906796106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer.

Authors:  Peter M Siegel; Joan Massagué
Journal:  Nat Rev Cancer       Date:  2003-11       Impact factor: 60.716

Review 2.  TGF-beta and epithelial-to-mesenchymal transitions.

Authors:  Jiri Zavadil; Erwin P Böttinger
Journal:  Oncogene       Date:  2005-08-29       Impact factor: 9.867

3.  beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium.

Authors:  Valerie M Weaver; Sophie Lelièvre; Johnathon N Lakins; Micah A Chrenek; Jonathan C R Jones; Filippo Giancotti; Zena Werb; Mina J Bissell
Journal:  Cancer Cell       Date:  2002-09       Impact factor: 31.743

Review 4.  Regulation of Par6 by extracellular signals.

Authors:  Rohit Bose; Jeffrey L Wrana
Journal:  Curr Opin Cell Biol       Date:  2006-02-20       Impact factor: 8.382

Review 5.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

6.  Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity.

Authors:  Barish Ozdamar; Rohit Bose; Miriam Barrios-Rodiles; Hong-Rui Wang; Yue Zhang; Jeffrey L Wrana
Journal:  Science       Date:  2005-03-11       Impact factor: 47.728

7.  Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

Authors:  William D Foulkes; Ingunn M Stefansson; Pierre O Chappuis; Louis R Bégin; John R Goffin; Nora Wong; Michel Trudel; Lars A Akslen
Journal:  J Natl Cancer Inst       Date:  2003-10-01       Impact factor: 13.506

8.  Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.

Authors:  Rebecca S Muraoka; Nancy Dumont; Christoph A Ritter; Teresa C Dugger; Dana M Brantley; Jin Chen; Evangeline Easterly; L Renee Roebuck; Sarah Ryan; Philip J Gotwals; Victor Koteliansky; Carlos L Arteaga
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

9.  Determination of TGFbeta1 protein level in human primary breast cancers and its relationship with survival.

Authors:  S Desruisseau; J Palmari; C Giusti; S Romain; P-M Martin; Y Berthois
Journal:  Br J Cancer       Date:  2006-01-30       Impact factor: 7.640

10.  Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors.

Authors:  Anita L Bane; Dushanthi Pinnaduwage; Sarah Colby; Michael Reedijk; Sean E Egan; Shelley B Bull; Frances P O'Malley; Irene L Andrulis
Journal:  Breast Cancer Res Treat       Date:  2008-06-18       Impact factor: 4.872

View more
  55 in total

Review 1.  Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions.

Authors:  Nathan J Godde; Ryan C Galea; Imogen A Elsum; Patrick O Humbert
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-12       Impact factor: 2.673

2.  Atypical protein kinase C (aPKCzeta and aPKClambda) is dispensable for mammalian hematopoietic stem cell activity and blood formation.

Authors:  Amitava Sengupta; Angeles Duran; Eri Ishikawa; Maria Carolina Florian; Susan K Dunn; Ashley M Ficker; Michael Leitges; Hartmut Geiger; Maria Diaz-Meco; Jorge Moscat; Jose A Cancelas
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-08       Impact factor: 11.205

Review 3.  Cancer stem cell division: when the rules of asymmetry are broken.

Authors:  Subhas Mukherjee; Jun Kong; Daniel J Brat
Journal:  Stem Cells Dev       Date:  2014-12-18       Impact factor: 3.272

4.  Multiple genes identified as targets for 20q13.12-13.33 gain contributing to unfavorable clinical outcomes in patients with hepatocellular carcinoma.

Authors:  Dong Wang; Zhong-Zheng Zhu; Hongmei Jiang; Jiayi Zhu; Wen-Ming Cong; Bing-Ji Wen; Song-Qin He; Shu-Fang Liu
Journal:  Hepatol Int       Date:  2015-06-12       Impact factor: 6.047

Review 5.  The regulation of cell-cell adhesion during epithelial-mesenchymal transition, motility and tumor progression.

Authors:  Grégoire F Le Bras; Kenneth J Taubenslag; Claudia D Andl
Journal:  Cell Adh Migr       Date:  2012-07-01       Impact factor: 3.405

Review 6.  The microRNA networks of TGFβ signaling in cancer.

Authors:  V P Sivadas; S Kannan
Journal:  Tumour Biol       Date:  2013-12-10

Review 7.  Polarity proteins as regulators of cell junction complexes: implications for breast cancer.

Authors:  Dana Bazzoun; Sophie Lelièvre; Rabih Talhouk
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

8.  Atypical protein kinase C phosphorylates Par6 and facilitates transforming growth factor β-induced epithelial-to-mesenchymal transition.

Authors:  Adrian Gunaratne; Boun L Thai; Gianni M Di Guglielmo
Journal:  Mol Cell Biol       Date:  2012-12-17       Impact factor: 4.272

9.  Loss of the Par3 polarity protein promotes breast tumorigenesis and metastasis.

Authors:  Luke Martin McCaffrey; JoAnne Montalbano; Constantina Mihai; Ian G Macara
Journal:  Cancer Cell       Date:  2012-11-13       Impact factor: 31.743

Review 10.  Cell polarity as a regulator of cancer cell behavior plasticity.

Authors:  Senthil K Muthuswamy; Bin Xue
Journal:  Annu Rev Cell Dev Biol       Date:  2012-08-06       Impact factor: 13.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.